# Novo Nordisk a S: Form 20-F for the period ended Dec 31, 2024

- Company: [Novo Nordisk a S](/companies/nvo.md) (CIK 353278)
- Form: 20-F
- Filed: 2025-02-05
- Accepted by EDGAR: Feb 5, 2025, 07:04 ET
- Period: 2024-12-31
- Accession: 0001628280-25-003920
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/nvo-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | DKK 290.40bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | DKK 44.52bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | DKK 245.88bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | DKK 128.34bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | DKK 26.20bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | DKK 100.99bn | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | DKK 22.63 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | DKK 22.67 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | DKK 120.97bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | DKK 47.16bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2024-12-31 | DKK 15.65bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2024-12-31 | DKK 160.90bn | ifrs-full:CurrentAssets |
| Total assets | at 2024-12-31 | DKK 465.80bn | ifrs-full:Assets |
| Current liabilities | at 2024-12-31 | DKK 217.53bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2024-12-31 | DKK 322.31bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2024-12-31 | DKK 143.49bn | ifrs-full:Equity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/nvo-20241231.htm

Filed Feb 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-003920. Last ingested by Listed: Nov 4, 2026, 07:48 ET. No prices; not investment advice.